CANCER ANTIGEN

摘要

Cancer cells when treated with cisplatin, paclitaxel, gemcitabine, Mycobacterium w or combination thereof show altered protein profile. Thus altered protein profile has at least one protein commonly expressed or over expressed. The commonly expressed or over expressed protein induces immune response specific to cancer cells (homologous and heterologous) of tissue/organ of origin. An immune response is generated by administration of commonly expressed or over expressed antigen not reactive to normal cells and cancer cells or different tissue/organ of origin.